Published in Sci Rep on October 04, 2017
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom (1994) 45.51
Mitochondria and apoptosis. Science (1998) 23.41
A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem (1984) 19.70
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol (2002) 14.17
Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science (2007) 8.56
Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov (2004) 5.82
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol (2013) 4.16
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 3.61
Antioxidant enzymes and human diseases. Clin Biochem (1999) 3.24
Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods (2014) 3.20
The pathophysiology and treatment of glaucoma: a review. JAMA (2014) 3.15
Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem (1999) 3.07
Complement and its role in innate and adaptive immune responses. Cell Res (2009) 3.07
Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol (2012) 3.03
Bidirectional relation between inflammation and coagulation. Circulation (2004) 3.00
Alzheimer's disease: the cholesterol connection. Nat Neurosci (2003) 2.99
Crystallins in the eye: Function and pathology. Prog Retin Eye Res (2007) 2.57
The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci (2012) 2.53
The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell (2015) 2.41
Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science (2016) 2.35
Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal (2009) 2.28
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci (2005) 2.02
Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal Chem (2012) 1.96
STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol (2012) 1.89
MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal Chem (2014) 1.81
Analysis of the Glutathione S-transferase M1 gene using pyrosequencing and multiplex PCR--no evidence of association to glaucoma. Exp Eye Res (2003) 1.74
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci (2005) 1.68
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta (2009) 1.66
Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett (1989) 1.66
Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med (2005) 1.63
Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol (2009) 1.57
A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS One (2011) 1.55
Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta (2011) 1.52
Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci (2006) 1.45
The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol (2012) 1.41
Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry (2016) 1.40
Expression of alpha B-crystallin in Alzheimer's disease. Acta Neuropathol (1994) 1.38
Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci (2009) 1.35
Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res (2011) 1.35
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.23
Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett (2010) 1.21
Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci (2010) 1.21
Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem (2009) 1.20
The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease. Invest Ophthalmol Vis Sci (2013) 1.20
Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma. Exp Eye Res (2010) 1.16
Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes. J Neurosci (2010) 1.15
Multiple roles of glutathione in the central nervous system. Biol Chem (1997) 1.14
Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases. Pharmaceuticals (Basel) (2010) 1.13
Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol (2009) 1.12
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS One (2012) 1.10
The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med (2015) 1.09
Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis (2012) 1.06
The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy. Mol Neurobiol (2012) 1.05
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement (2015) 1.03
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease. J Neuroinflammation (2011) 1.02
Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population. Br J Ophthalmol (2006) 1.01
Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand (1999) 1.01
Defining the consequences of genetic variation on a proteome-wide scale. Nature (2016) 0.96
Alzheimer's disease and glaucoma: mechanistic similarities and differences. J Glaucoma (2013) 0.94
Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord (2015) 0.93
Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin Lipidol (2010) 0.93
Mutations in mitochondrial ribosomal protein MRPL12 leads to growth retardation, neurological deterioration and mitochondrial translation deficiency. Biochim Biophys Acta (2013) 0.92
BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma. Biochim Biophys Acta (2014) 0.92
Ocular biomarkers for early detection of Alzheimer's disease. J Alzheimers Dis (2010) 0.92
Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Invest Ophthalmol Vis Sci (2009) 0.91
Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett (2007) 0.90
Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener (2016) 0.87
Glutathione S-transferase GSTM 1, null genotype may be associated with susceptibility to age-related cataract. Adv Clin Exp Med (2015) 0.84
Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Alzheimers Dement (Amst) (2015) 0.83
Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis. PLoS One (2014) 0.82
Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol Vis Sci (2014) 0.81
Glaucoma related Proteomic Alterations in Human Retina Samples. Sci Rep (2016) 0.81
Elevated levels of multiple biomarkers of Alzheimer's disease in the aqueous humor of eyes with open-angle glaucoma. Invest Ophthalmol Vis Sci (2013) 0.80
Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: a meta-analysis. J Neurol Sci (2013) 0.79
Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse. Neurosci Lett (2016) 0.79
Crystallin-β-b2-overexpressing NPCs support the survival of injured retinal ganglion cells and photoreceptors in rats. Invest Ophthalmol Vis Sci (2012) 0.78
βB2-Crystallin Promotes Axonal Regeneration in the Injured Optic Nerve in Adult Rats. Cell Transplant (2014) 0.78
One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina. Cell Mol Life Sci (2016) 0.77
Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma. J Ocul Pharmacol Ther (2014) 0.77
GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis. Mol Neurobiol (2015) 0.76
The effect of GSTT1, GSTM1 and GSTP1 gene polymorphisms on the susceptibility of age-related cataract in Chinese Han population. Int J Clin Exp Med (2015) 0.76
Omics Biomarkers in Ophthalmology. Invest Ophthalmol Vis Sci (2017) 0.76
Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma. PLoS One (2017) 0.75
Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease. PLoS One (2016) 0.75
Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci (2013) 3.94
A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides. Nat Biotechnol (2015) 1.30
Enzyme clustering accelerates processing of intermediates through metabolic channeling. Nat Biotechnol (2014) 1.11
Unique roles for histone H3K9me states in RNAi and heritable silencing of transcription. Nature (2017) 1.08
Extended ubiquitin species are protein-based DUB inhibitors. Nat Chem Biol (2014) 0.86
The number of alphaherpesvirus particles infecting axons and the axonal protein repertoire determines the outcome of neuronal infection. MBio (2015) 0.82
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease. Prog Neurobiol (2016) 0.79
Two Modes of the Axonal Interferon Response Limit Alphaherpesvirus Neuroinvasion. MBio (2016) 0.79
Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma. PLoS One (2015) 0.78
Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy. Phytother Res (2016) 0.78
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis. Brain Res (2013) 0.77
Role of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity. J Virol (2016) 0.76
Induction of virulence factors in Giardia duodenalis independent of host attachment. Sci Rep (2016) 0.76
Temporal Regulation of the Bacillus subtilis Acetylome and Evidence for a Role of MreB Acetylation in Cell Wall Growth. mSystems (2016) 0.76
Topoisomerase I inhibition leads to length-dependent gene expression changes in human primary astrocytes. Genom Data (2016) 0.75
Structural Analysis of Mycobacterium tuberculosis Homologues of the Eukaryotic Proteasome Assembly Chaperone 2 (PAC2). J Bacteriol (2017) 0.75
Extended exposure to sugar and/or caffeine produces distinct behavioral and neurochemical profiles in the orbitofrontal cortex of rats: Implications for neural function. Proteomics (2016) 0.75
Amyloid-beta peptide neurotoxicity in human neuronal cells is associated with modulation of insulin-like growth factor transport, lysosomal machinery and extracellular matrix receptor interactions. Neural Regen Res (2020) 0.75
Molecular targets of Tannic Acid in Alzheimer’s disease Curr Alzheimer Res (2017) 0.75
Resveratrol and Alzheimer's Disease: Mechanistic Insights. Mol Neurobiol (2016) 0.75
Quantitative shotgun proteomics reveals extensive changes to the proteome of the orbitofrontal cortex in rats that are hyperactive following withdrawal from a high sugar diet. Proteomics (2016) 0.75
Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons. Metab Brain Dis (2014) 0.75